AzurRx BioPharma, Inc.
(NASDAQ : AZRX)

( )
AZRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.11%358.111.2%$821.20m
AMGNAmgen Inc.
-0.54%191.761.2%$548.88m
CELGCelgene Corporation
-0.51%85.341.2%$519.45m
GILDGilead Sciences, Inc.
-0.09%77.050.9%$473.46m
VRTXVertex Pharmaceuticals Incorporated
-0.56%180.121.9%$315.55m
REGNRegeneron Pharmaceuticals, Inc.
0.48%367.742.6%$284.44m
ILMNIllumina, Inc.
0.59%309.103.5%$264.44m
SRPTSarepta Therapeutics, Inc.
0.14%135.5316.6%$232.12m
BLUEBluebird Bio, Inc.
-0.33%178.9515.7%$201.94m
ALXNAlexion Pharmaceuticals, Inc.
-0.41%135.092.0%$176.54m
NKTRNektar Therapeutics
2.51%49.085.6%$174.06m
EXASExact Sciences Corporation
1.30%67.6125.4%$158.76m
EXELExelixis, Inc.
0.05%21.346.4%$136.40m
BMRNBioMarin Pharmaceutical Inc.
0.18%102.874.4%$125.14m
AAgilent Technologies, Inc.
1.84%64.151.5%$122.61m

Company Profile

AzurRx BioPharma, Inc. is a development stage company, which engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It offers MS1819 and AZX1101 that are therapeutic proteins products under development. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.